Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

INFECTIOUS DISEASES SOCIETY OF AMERICA

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
06b30c7b-b19d-42f9-9c4a-c3d34447a0ff
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally

BUD · Budget/Appropriations

Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally Reauthorization of Bio-Preparedness Workforce Pilot Program H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally

Literal federal measure citations: H. Con. Res 14, S. Con. Res 7, H.R. 1

MMM · Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.